This always happens a few months before a decision from EU or FDA. If you have cash load up some more. TRIUS and others I have owned you'd think they were going to zero; however, the either soared on approvals, or were bought out.
point & figure charts gives this a bullish price signal reversal on Feb.3/14 with a $7.50 price objective target. Hope we have something happen before May. The vol. is non existent so no one is selling nor buying. Liquidity has all but dried up. Could see some wild swings; worth adding to if you want to pick up more shares cheaper.